Naloxone shortage goes national in wave of opioid overdose
Public trust in a federal access program for the overdose drug Naloxone has been shaken after more than a year of shortages ...
Inquirer on MSN7h
World’s first anti-depression nasal spray receives FDA approval
The US Food and Drug Administration (FDA) approved the first-ever anti-depression nasal spray, Spravato. The pharmaceutical company Johnson & Johnson created the spray from esketamine, a more potent ...
BioSpace22h
GH’s Inhaled Psychedelic Succeeds in Mid-Stage Depression Trial
In a Phase IIb trial, GH001 elicited significant drops in treatment-resistant depression. The news comes less than two weeks ...